Moreover, the inhibition of vascular-endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and fibroblast growth factor (FGF) signaling pathways reduces tumor angiogenesis in the lung and consequently could potentially contribute to the reduction of LAM cell dissemination and the progression of the disease [38,39]. This evidence concerns the gene VEGFA and neoplasm.